Workup for Suspected Vasculitis
For patients suspected of having vasculitis, a comprehensive diagnostic workup should include biopsy of affected tissue, ANCA testing with immunofluorescence and ELISA for PR3/MPO antibodies, laboratory studies, and appropriate imaging based on suspected vessel size involvement. 1
Initial Assessment and Classification
Disease Classification: Categorize based on vessel size and clinical presentation:
- Large vessel: Takayasu arteritis, giant cell arteritis
- Medium vessel: Polyarteritis nodosa
- Small vessel: ANCA-associated vasculitis (GPA, MPA, EGPA), IgA vasculitis
Clinical Assessment: Use validated tools like Birmingham Vasculitis Activity Score (BVAS) to assess disease activity and guide treatment decisions 1
Essential Diagnostic Tests
Biopsy
- Gold standard for diagnosis - strongly recommended to establish new diagnosis or evaluate suspected relapse 2
- Target selection based on affected organ:
Laboratory Testing
ANCA Testing:
Basic Laboratory Studies:
- Complete blood count with differential
- Comprehensive metabolic panel
- Inflammatory markers: ESR and CRP
- Renal function: Serum creatinine, eGFR
- Urinalysis with microscopic examination and protein quantification 1
Additional Serologic Testing:
Imaging Studies
- Select based on suspected vessel size 1:
Vessel Size Recommended Imaging Large CT/CTA, MRI/MRA, or FDG-PET/CT Medium CTA of affected regions (renal, mesenteric, coronary) Small MRI/MRA or FDG-PET/CT
Organ-Specific Evaluation
Renal Assessment
- Urinalysis with microscopic examination (hematuria, proteinuria)
- Protein/creatinine ratio
- Renal function tests
- Renal biopsy if indicated (gold standard for diagnosis of renal vasculitis) 1
Pulmonary Assessment
- Chest imaging (CT preferred over X-ray)
- Pulmonary function tests
- Bronchoscopy with bronchoalveolar lavage if pulmonary hemorrhage suspected
- Lung biopsy when appropriate 1
ENT Assessment
- Nasal endoscopy
- Sinus CT scan
- Biopsy of suspicious lesions 2
Important Considerations
Do not delay treatment in rapidly deteriorating patients with clinical presentation compatible with small-vessel vasculitis and positive MPO or PR3-ANCA while waiting for biopsy results 1
Refer to centers of expertise for complex cases or refractory disease, as AAV requires multidisciplinary management 2
Structured clinical assessment rather than ANCA testing alone should guide treatment decisions 2
Monitor for treatment complications including infections, which are common in treated patients 1
Common Pitfalls to Avoid
- Relying solely on ANCA testing without clinical correlation
- Delaying treatment in severe cases while waiting for biopsy results
- Failing to assess for specific organ involvement comprehensively
- Not considering mimics of vasculitis (infections, malignancy, drug reactions)
- Overlooking the need for periodic cardiovascular risk assessment in patients with vasculitis 1
By following this structured approach to diagnosis, clinicians can efficiently identify and classify vasculitis, enabling prompt initiation of appropriate treatment to improve outcomes and reduce morbidity and mortality.